Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors rely on traditional forms of analysis on key ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors rely on traditional forms of a ...

For those looking to find strong Computer and Technology stocks, it is prudent to search for companies in the group that are outperforming their peers. CyberAgent (CYGIY) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.CyberAgent is a member of the Computer and Technology sector. This group includes 608 individual stocks and currently holds a ...

Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. Pagaya Technologies Ltd. (PGY) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.Pagaya Technologies Ltd. is a member of the Finance sector. This group includes 857 individual stocks and currently holds a Zacks Sector Rank of #4. T ...

Investors interested in Basic Materials stocks should always be looking to find the best-performing companies in the group. HudBay Minerals (HBM) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.HudBay Minerals is a member of our Basic Materials group, which includes 233 different companies and currently sits at #12 in the Zacks Sector Rank. Th ...

The Business Services group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. BGSF (BGSF) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Business Services sector should help us answer this question.BGSF is a member of our Business Services group, which includes 27 ...

Investors interested in Transportation stocks should always be looking to find the best-performing companies in the group. Is Flex LNG (FLNG) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Transportation sector should help us answer this question.Flex LNG is a member of the Transportation sector. This group includes 122 individual stocks and currently holds a Zacks Sector Rank of #14. The Zacks Sector Rank includes 16 different groups ...

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Cardinal Health (CAH), and emphasizes the importance of using these recommendations in conjunction with other analytical tools like the Zacks Rank for making informed investment decisions [1][5][10]. Group 1: Brokerage Recommendations - Cardinal Health has an average brokerage recommendation (ABR) of 1.43, indicating a consensus between Strong Buy and Buy, based on recommendations from 14 brokerage firms [2]. - Out of the 14 recommendations, 11 are classified as Strong Buy, accounting for 78.6% of all recommendations [2]. - Despite the positive ABR, reliance solely on brokerage recommendations may not be prudent, as studies indicate limited success in guiding investors towards stocks with the highest price increase potential [5][10]. Group 2: Zacks Rank vs. ABR - The Zacks Rank is a proprietary stock rating tool that classifies stocks into five groups based on earnings estimate revisions, providing a more reliable indicator of near-term price performance compared to ABR [8][11]. - The Zacks Rank is updated more frequently and reflects changes in earnings estimates, making it a timely tool for predicting future price movements [12]. - Cardinal Health's Zacks Consensus Estimate for the current year has increased by 0.9% to $8.16, indicating growing optimism among analysts regarding the company's earnings prospects [13]. Group 3: Investment Implications - The recent change in the consensus estimate, along with other factors, has resulted in a Zacks Rank 2 (Buy) for Cardinal Health, suggesting a favorable outlook for the stock [14]. - The Buy-equivalent ABR for Cardinal may serve as a useful guide for investors when combined with the Zacks Rank [14].

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Alphabet (GOOGL), and emphasizes the importance of using these recommendations in conjunction with other analytical tools for making investment decisions [1][5]. Brokerage Recommendations - Alphabet has an average brokerage recommendation (ABR) of 1.38, indicating a consensus between Strong Buy and Buy, based on recommendations from 52 brokerage firms [2]. - Out of the 52 recommendations, 40 are classified as Strong Buy, accounting for 76.9%, while four are classified as Buy, making up 7.7% of the total [2]. Limitations of Brokerage Recommendations - Relying solely on brokerage recommendations may not be wise, as studies indicate limited success in guiding investors towards stocks with the highest price increase potential [5]. - Brokerage firms often exhibit a positive bias in their ratings due to vested interests, leading to a disproportionate number of Strong Buy recommendations compared to Strong Sell recommendations [6][10]. Zacks Rank as an Alternative - The Zacks Rank, which classifies stocks into five groups based on earnings estimate revisions, is presented as a more reliable indicator of near-term price performance compared to ABR [8][11]. - The Zacks Rank is timely and reflects the latest earnings estimate revisions, unlike the potentially outdated ABR [12]. Current Earnings Estimates for Alphabet - The Zacks Consensus Estimate for Alphabet's current year earnings remains unchanged at $9.51, suggesting stability in analysts' views regarding the company's earnings prospects [13]. - Due to the unchanged consensus estimate and other factors, Alphabet holds a Zacks Rank of 3 (Hold), indicating a cautious approach despite the Buy-equivalent ABR [14].

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Teradyne (TER), and highlights the potential misalignment of interests between brokerage analysts and retail investors [1][5][10]. Group 1: Brokerage Recommendations for Teradyne - Teradyne has an average brokerage recommendation (ABR) of 1.93, indicating a consensus between Strong Buy and Buy, with 60% of recommendations being Strong Buy and 6.7% being Buy [2][4]. - The article suggests that relying solely on the ABR for investment decisions may not be advisable, as studies indicate that brokerage recommendations often fail to guide investors effectively [5][10]. Group 2: Limitations of Brokerage Recommendations - Brokerage analysts tend to exhibit a strong positive bias in their ratings due to vested interests, resulting in a disproportionate number of favorable ratings compared to negative ones [6][10]. - The article emphasizes that the best use of brokerage recommendations is to validate independent research rather than as a primary decision-making tool [7][10]. Group 3: Zacks Rank vs. ABR - Zacks Rank is presented as a more reliable tool for predicting stock performance, based on earnings estimate revisions, and is categorized into five groups from Strong Buy to Strong Sell [8][11]. - Unlike ABR, which may not be up-to-date, Zacks Rank reflects timely changes in earnings estimates, making it a more effective indicator for future stock prices [12]. Group 4: Current Earnings Estimates for Teradyne - The Zacks Consensus Estimate for Teradyne remains unchanged at $3.16 for the current year, suggesting stable analyst views on the company's earnings prospects [13]. - Due to the unchanged consensus estimate and other factors, Teradyne holds a Zacks Rank of 3 (Hold), indicating a cautious approach despite the Buy-equivalent ABR [14].